<VariationArchive VariationID="1726400" VariationName="NM_000426.4(LAMA2):c.2916del (p.Phe972fs)" VariationType="Deletion" Accession="VCV001726400" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2022-11-19" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1783927" VariationID="1726400">
      <GeneList>
        <Gene Symbol="LAMA2" FullName="laminin subunit alpha 2" GeneID="3908" HGNC_ID="HGNC:6482" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="128883138" stop="129516566" display_start="128883138" display_stop="129516566" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="129204285" stop="129837710" display_start="129204285" display_stop="129837710" Strand="+" />
          </Location>
          <OMIM>156225</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000426.4(LAMA2):c.2916del (p.Phe972fs)</Name>
      <CanonicalSPDI>NC_000006.12:129297740:TTTT:TTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q22.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="129297741" stop="129297741" display_start="129297741" display_stop="129297741" variantLength="1" positionVCF="129297740" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="129618886" stop="129618886" display_start="129618886" display_stop="129618886" variantLength="1" positionVCF="129618885" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>F972fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.129618889del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.129618889del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.129297744del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.129297744del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008678.1" sequenceAccession="NG_008678" sequenceVersion="1" change="g.419604del">
            <Expression>NG_008678.1:g.419604del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000426.4" sequenceAccession="NM_000426" sequenceVersion="4" change="c.2916del" MANESelect="true">
            <Expression>NM_000426.4:c.2916del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000417.3" sequenceAccession="NP_000417" sequenceVersion="3" change="p.Phe972fs">
            <Expression>NP_000417.3:p.Phe972fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079823.2" sequenceAccession="NM_001079823" sequenceVersion="2" change="c.2916del">
            <Expression>NM_001079823.2:c.2916del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001073291.2" sequenceAccession="NP_001073291" sequenceVersion="2" change="p.Phe972fs">
            <Expression>NP_001073291.2:p.Phe972fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_409" sequenceAccession="LRG_409">
            <Expression>LRG_409:g.419604del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_409t1" sequenceAccession="LRG_409t1">
            <Expression>LRG_409t1:c.2916del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_409p1" sequenceAccession="LRG_409p1" change="p.Phe972Leufs">
            <Expression>LRG_409p1:p.Phe972Leufs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000426.4(LAMA2):c.2916del (p.Phe972fs) AND multiple conditions" Accession="RCV002310084" Version="2">
        <ClassifiedConditionList TraitSetID="46927">
          <ClassifiedCondition DB="MedGen" ID="C1263858">Merosin deficient congenital muscular dystrophy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4748327">Muscular dystrophy, limb-girdle, autosomal recessive 23</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-17" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000426.4(LAMA2):c.2916del (p.Phe972fs) AND LAMA2-related muscular dystrophy" Accession="RCV003102299" Version="2">
        <ClassifiedConditionList TraitSetID="9616">
          <ClassifiedCondition DB="MedGen" ID="C5679788">LAMA2-related muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-02" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-11-19" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18700894</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32904964</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="46927" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="40685" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy, limb-girdle, autosomal recessive 23</ElementValue>
                <XRef ID="MONDO:0029136" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LGMDR23</ElementValue>
                <XRef Type="MIM" ID="618138" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The clinical manifestations of LAMA2 muscular dystrophy (LAMA2-MD) comprise a continuous spectrum ranging from severe congenital muscular dystrophy type 1A (MDC1A) to milder late-onset LAMA2-MD. MDC1A is typically characterized by neonatal profound hypotonia, poor spontaneous movements, and respiratory failure. Failure to thrive, gastroesophageal reflux, aspiration, and recurrent chest infections necessitating frequent hospitalizations are common. As disease progresses, facial muscle weakness, temporomandibular joint contractures, and macroglossia may further impair feeding and can affect speech. In late-onset LAMA2-MD onset of manifestations range from early childhood to adulthood. Affected individuals may show muscle hypertrophy and develop a rigid spine syndrome with joint contractures, usually most prominent in the elbows. Progressive respiratory insufficiency, scoliosis, and cardiomyopathy can occur.</Attribute>
                <XRef ID="NBK97333" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="22270" />
                <XRef ID="22270" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22675738</ID>
                <ID Source="BookShelf">NBK97333</ID>
              </Citation>
              <XRef ID="565837" DB="Orphanet" />
              <XRef ID="C4748327" DB="MedGen" />
              <XRef ID="MONDO:0029136" DB="MONDO" />
              <XRef Type="MIM" ID="618138" DB="OMIM" />
            </Trait>
            <Trait ID="3057" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy congenital, merosin negative</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Merosin deficient congenital muscular dystrophy</ElementValue>
                <XRef ID="Muscular+dystrophy+congenital%2C+merosin+negative/4985" DB="Genetic Alliance" />
                <XRef ID="111503008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital merosin-deficient muscular dystrophy 1A</ElementValue>
                <XRef ID="MONDO:0011925" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDC1A</ElementValue>
                <XRef Type="MIM" ID="607855" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3843" />
                <XRef ID="3843" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ISCCCMD, 2010">
                <ID Source="PubMed">21078917</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22420014</ID>
                <ID Source="BookShelf">NBK84550</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22675738</ID>
                <ID Source="BookShelf">NBK97333</ID>
              </Citation>
              <XRef ID="258" DB="Orphanet" />
              <XRef ID="C1263858" DB="MedGen" />
              <XRef ID="MONDO:0011925" DB="MONDO" />
              <XRef Type="MIM" ID="607855" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16601" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Laminin alpha 2-related dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">LAMA2-related muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0100228" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LAMA2-RD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The clinical manifestations of LAMA2 muscular dystrophy (LAMA2-MD) comprise a continuous spectrum ranging from severe congenital muscular dystrophy type 1A (MDC1A) to milder late-onset LAMA2-MD. MDC1A is typically characterized by neonatal profound hypotonia, poor spontaneous movements, and respiratory failure. Failure to thrive, gastroesophageal reflux, aspiration, and recurrent chest infections necessitating frequent hospitalizations are common. As disease progresses, facial muscle weakness, temporomandibular joint contractures, and macroglossia may further impair feeding and can affect speech. In late-onset LAMA2-MD onset of manifestations range from early childhood to adulthood. Affected individuals may show muscle hypertrophy and develop a rigid spine syndrome with joint contractures, usually most prominent in the elbows. Progressive respiratory insufficiency, scoliosis, and cardiomyopathy can occur.</Attribute>
                <XRef ID="NBK97333" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22675738</ID>
                <ID Source="BookShelf">NBK97333</ID>
              </Citation>
              <XRef ID="C5679788" DB="MedGen" />
              <XRef ID="MONDO:0100228" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5085702" SubmissionDate="2022-11-17" DateLastUpdated="2022-12-24" DateCreated="2022-11-19">
        <ClinVarSubmissionID localKey="12674631|OMIM:607855;OMIM:618138" />
        <ClinVarAccession Accession="SCV002604843" DateUpdated="2022-12-24" DateCreated="2022-11-19" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>NM_000426.3(LAMA2):c.2916delT(F972Lfs*103) is expected to be pathogenic in the context of muscular dystrophy, LAMA2-related. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in LAMA2, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2021)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/wpe7ty9o/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2021_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" alternateAllele="C" referenceAllele="CT" start="129618885" stop="129618886" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">12674631</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="618138" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607855" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12292560</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6027589" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16308212|MedGen:CN117977" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003339646" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18700894</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32904964</ID>
          </Citation>
          <Comment>This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with LAMA2-related conditions. This sequence change creates a premature translational stop signal (p.Phe972Leufs*103) in the LAMA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMA2 are known to be pathogenic (PMID: 18700894, 32904964).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.129618886del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN117977" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5085702" TraitType="Disease" MappingType="XRef" MappingValue="618138" MappingRef="OMIM">
        <MedGen CUI="C4748327" Name="Muscular dystrophy, limb-girdle, autosomal recessive 23" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6027589" TraitType="Disease" MappingType="XRef" MappingValue="CN117977" MappingRef="MedGen">
        <MedGen CUI="C5679788" Name="LAMA2-related muscular dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5085702" TraitType="Disease" MappingType="XRef" MappingValue="607855" MappingRef="OMIM">
        <MedGen CUI="C1263858" Name="Merosin deficient congenital muscular dystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

